 Connection
Janet Snell-Bergeon to Haptoglobins
This is a "connection" page, showing publications Janet Snell-Bergeon has written about Haptoglobins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.309 |
|
|
|
-
Costacou T, Levy AP, Miller RG, Snell-Bergeon J, Asleh R, Farbstein D, Fickley CE, Pambianco G, de la Vega R, Evans RW, Orchard TJ. Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial. Acta Diabetol. 2016 Apr; 53(2):243-50.
Score: 0.116
-
Levy NS, Vardi M, Blum S, Miller-Lotan R, Afinbinder Y, Cleary PA, Paterson AD, Bharaj B, Snell-Bergeon JK, Rewers MJ, Lache O, Levy AP. An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype. Clin Chem Lab Med. 2013 Aug; 51(8):1615-22.
Score: 0.102
-
Simpson M, Snell-Bergeon JK, Kinney GL, Lache O, Miller-Lotan R, Anbinder Y, Rewers MJ, Levy AP. Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes. Cardiovasc Diabetol. 2011 Nov 20; 10:99.
Score: 0.091
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|